These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29983907)

  • 1. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management.
    Bachert C; Bousquet J; Hellings P
    Clin Transl Allergy; 2018; 8():25. PubMed ID: 29983907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhinology future trends: 2017 EUFOREA debate on allergic rhinitis.
    Scadding G; Bousquet J; Bachert C; Fokkens WJ; Hellings PW; Prokopakis E; Pfaar O; Price D
    Rhinology; 2019 Feb; 57(1):49-56. PubMed ID: 30052697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
    Klimek L; Berger WE; Bousquet J; Keith PK; Smith P; Sole D; Scadding G; Kuhl HC; Nguyen DT; Kopietz F; Koltun A
    Int Arch Allergy Immunol; 2021; 182(11):1026-1035. PubMed ID: 34082425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE; Meltzer EO
    Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US.
    Prenner BM
    J Asthma Allergy; 2016; 9():135-43. PubMed ID: 27468241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
    Kaulsay R; Nguyen DT; Kuhl HC
    Immun Inflamm Dis; 2018 Dec; 6(4):456-464. PubMed ID: 30306729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
    Haahr PA; Jacobsen C; Christensen ME
    Int Forum Allergy Rhinol; 2019 Apr; 9(4):388-395. PubMed ID: 30659752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
    Scadding G; Price D; El-Shanawany T; Ahmed S; Ray J; Sargur R; Kumar N
    BMJ Open; 2017 Apr; 7(4):e014777. PubMed ID: 28442578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.
    Bousquet J; Meltzer EO; Couroux P; Koltun A; Kopietz F; Munzel U; Kuhl HC; Nguyen DT; Salapatek AM; Price D
    J Allergy Clin Immunol Pract; 2018; 6(5):1726-1732.e6. PubMed ID: 29425904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers.
    Roca-Ferrer J; Pujols L; Pérez-González M; Alobid I; Callejas B; Vicens-Artés S; Fuentes M; Valero A; Picado C; Castor D; Nguyen D; Mullol J
    Allergy Asthma Clin Immunol; 2018; 14():86. PubMed ID: 30574167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
    Berger W; Meltzer EO; Amar N; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Bousquet J
    Pediatr Allergy Immunol; 2016 Mar; 27(2):126-33. PubMed ID: 26928753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children.
    Berger W; Bousquet J; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Wahn U
    Allergy; 2016 Aug; 71(8):1219-22. PubMed ID: 27043452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis.
    Zhong Z; Xun Y; Shi X; Guan B; Wang M
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2457-2464. PubMed ID: 34415405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells.
    Berger WE; Bachert C; Allara R; Koltun A; Kopietz F; Maus JG; D'Addio AD
    J Asthma Allergy; 2020; 13():187-192. PubMed ID: 32547111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
    Ilyina NI; Edin AS; Astafieva NG; Lopatin AS; Sidorenko IV; Ukhanova OP; Khanova FM
    Int Arch Allergy Immunol; 2019; 178(3):255-263. PubMed ID: 30677766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-Life Effectiveness of MP-AzeFlu (Dymista
    Stjärne P; Nguyen DT; Kuhl HC
    Pragmat Obs Res; 2023; 14():1-11. PubMed ID: 36628265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma.
    Price D; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
    Clin Mol Allergy; 2020; 18():15. PubMed ID: 32782442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
    Harrow B; Sedaghat AR; Caldwell-Tarr A; Dufour R
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1426-1436. PubMed ID: 27882840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MP29-02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite-allergic rhinitis.
    Kortekaas Krohn I; Callebaut I; Alpizar YA; Steelant B; Van Gerven L; Skov PS; Kasran A; Talavera K; Wouters MM; Ceuppens JL; Seys SF; Hellings PW
    Allergy; 2018 May; 73(5):1084-1093. PubMed ID: 29121401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
    Klimek L; Demoly P; Price D
    Expert Rev Clin Pharmacol; 2016; 9(5):705-14. PubMed ID: 26839083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.